Timber Pharmaceuticals Inc (TMBR)

Overview News Price History Discussions Forecast Stock Split

Timber Pharmaceuticals Inc stock is currently priced at $0.00, with a 24-hour trading volume of 0. It has seen a -100.00% decreased in the last 24 hours and a -100.00% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $0.3376 pivot point. If it approaches the $0.2954 support level, significant changes may occur.

Timber Pharmaceuticals Inc Stock (TMBR) Financials Data

There is no financial data for Timber Pharmaceuticals Inc (TMBR). Check out other stocks for more information.

Timber Pharmaceuticals Inc Stock (TMBR) Latest News

Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market

GlobeNewswire Inc.

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

GlobeNewswire Inc.

Timber Pharmaceuticals LLC, a clinical-stage medical dermatology company, focuses on the development and commercialization of pharmaceuticals for treatment of orphan dermatologic diseases. The company was founded in 2019 and is based in Woodcliff Lake, New Jersey.